EVENITY

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug EVENITY contains one active pharmaceutical ingredient (API):

1 Romosozumab UNII 3VHF2ZD92J - ROMOSOZUMAB

Romosozumab is a humanized monoclonal antibody (IgG2) that binds and inhibits sclerostin, thereby increasing bone formation, bone matrix production and recruitment of osteoprogenitor cells. Additionally, romosozumab results in changes to expression of osteoclast mediators, thereby decreasing bone resorption. It is indicated in treatment of severe osteoporosis in postmenopausal women at high risk of fracture. Read about Romosozumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EVENITY Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BX06		M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BX Other drugs affecting bone structure and mineralization
Discover more medicines within M05BX06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12301K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 544121030005402
Country: CA	Health Products and Food Branch	Identifier(s): 02489597
Country: EE	Ravimiamet	Identifier(s): 1808524, 1808535, 1808546, 1808557
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 381593
Country: HK	Department of Health Drug Office	Identifier(s): 66741
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8507
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999449G1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089061, 1089063, 1089064, 1089065
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 207063
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100429823, 100429830
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68906001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699862950244
Country: US	FDA, National Drug Code	Identifier(s): 55513-880